SCHEMBL8285191

SCHEMBL8285191

Cc1nc2c(cc1-c1cccnc1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.41
MAPT P10636 4/20 0.41
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABL1 P00519 1/20 0.39
EGFR P00533 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCD Q05655 1/20 0.39
G6PD P11413 1/20 0.38
AURKA O14965 1/20 0.38
HPGD P15428 1/20 0.38
PDE11A Q9HCR9 1/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285224 0.91 PDE11A (0.41) MAPTKDM4EGAASMN1; SMN2CYP2C9
SCHEMBL8285227 0.84 PDE11A (0.40) KDM4EGAACYP1A2CYP3A4CYP2C19
SCHEMBL8287380 0.82 CYP1A2 (0.46) MAPTSMN1; SMN2CYP1A2CYP3A4POLB
SCHEMBL8285206 0.82 PDE11A (0.43) MAPTKDM4EGAASMN1; SMN2CYP1A2
SCHEMBL5871894 0.81 PDE11A (0.43) KDM4EGAASMN1; SMN2CYP1A2CYP3A4
SCHEMBL8362692 0.80 CYP1A2 (0.40) EGLN1MAPTKDM4EGAASMN1; SMN2
SCHEMBL8287451 0.80 PDE11A (0.42) KDM4EGAASMN1; SMN2CYP1A2CYP3A4
SCHEMBL8285237 0.79 ALDH1A1 (0.41) MAPTKDM4EGAASMN1; SMN2HPGD
SCHEMBL8285194 0.79 ALDH1A1 (0.43) MAPTKDM4EGAASMN1; SMN2CYP1A2
SCHEMBL8361773 0.79 PDE11A (0.44) MAPTKDM4EGAASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed